BRAINSTORM CELL THERAPEUTICS INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Brainstorm Cell Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Brainstorm Cell Therapeutics Inc. Debt-to-equity for the quarter ending September 30, 2024 was -176 %, a 40% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -176 +117 +40% Sep 30, 2024
Q2 2024 -215 +227 +51.4% Jun 30, 2024
Q1 2024 -213 -3.62K -106% Mar 31, 2024
Q4 2023 -245 -466 -211% Dec 31, 2023
Q3 2023 -294 -396 -386% Sep 30, 2023
Q2 2023 -441 -504 -801% Jun 30, 2023
Q1 2023 3.41K +3.36K +6960% Mar 31, 2023
Q4 2022 221 +181 +456% Dec 31, 2022
Q3 2022 103 +63.4 +161% Sep 30, 2022
Q2 2022 63 +26.3 +71.5% Jun 30, 2022
Q1 2022 48.3 +7.06 +17.1% Mar 31, 2022
Q4 2021 39.8 -11.3 -22.1% Dec 31, 2021
Q3 2021 39.3 -95.5 -70.8% Sep 30, 2021
Q2 2021 36.7 +31.1K Jun 30, 2021
Q1 2021 41.2 +426 Mar 31, 2021
Q4 2020 51 +302 Dec 31, 2020
Q3 2020 135 +903 Sep 30, 2020
Q2 2020 -31K -31.3K -9701% Jun 30, 2020
Q1 2020 -385 -490 -465% Mar 31, 2020
Q4 2019 -251 -326 -436% Dec 31, 2019
Q3 2019 -768 -839 -1185% Sep 30, 2019
Q2 2019 323 Jun 30, 2019
Q1 2019 105 Mar 31, 2019
Q4 2018 74.9 Dec 31, 2018
Q3 2018 70.8 Sep 30, 2018
Q4 2015 16.4 -24.2 -59.5% Dec 31, 2015
Q3 2015 19 -23.2 -55% Sep 30, 2015
Q2 2015 20.7 -26.9 -56.5% Jun 30, 2015
Q1 2015 22.7 -57.8 -71.8% Mar 31, 2015
Q4 2014 40.7 -7.96 -16.4% Dec 31, 2014
Q3 2014 42.2 +3.56 +9.22% Sep 30, 2014
Q2 2014 47.6 +11.7 +32.6% Jun 30, 2014
Q1 2014 80.4 +37 +85.2% Mar 31, 2014
Q4 2013 48.6 -8.65 -15.1% Dec 31, 2013
Q3 2013 38.6 -40.4 -51.1% Sep 30, 2013
Q2 2013 35.9 -70.2 -66.2% Jun 30, 2013
Q1 2013 43.4 -28.7 -39.8% Mar 31, 2013
Q4 2012 57.3 Dec 31, 2012
Q3 2012 79.1 Sep 30, 2012
Q2 2012 106 Jun 30, 2012
Q1 2012 72.1 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.